OBJECTIVE: The aim of this guideline is the treatment of patients with SARS CoV-2 (COVID-19) in hospital; in particular, it addresses the treatment of respiratory failure treated in general Internal Medical- and Pulmonary Medical wards.
RESULTS: Elderly patients and patients with chronic disease are particularly vulnerable to COVID-19. Target oxygen saturation should be between 92% and 96% in patients without chronic lung diseases. Treatment with >5 L oxygen/min should be in close collaboration with intensive care colleagues and >15 l/min preferably in intensive care units. High-flow nasal canula (HFNC) and long-term Continuous Positive Airway Pressure (CPAP) are recommended for patients not responding to conventional oxygen therapy. Non-invasive ventilation (NIV) is only recommended for selected patients, such as those with a ceiling of treatment or patients presenting with hypercapnic failure. With the use of humidification protective equipment as FFP2-3 masks should be used. Nebulized medication should be avoided, and spacers should be used instead.
CONCLUSIONS: Respiratory failure is frequently the cause of hospitalization in patients with COVID-19 and should be monitored closely.
目的:本指南的目的是在医院治疗SARSCoV-2(COVID-19)患者;特别是,它解决了在一般内科和肺部医学病房治疗的呼吸衰竭的治疗。
结果:老年患者和慢性病患者特别容易感染COVID-19。在没有慢性肺部疾病的患者中,目标氧饱和度应在92%至96%之间。>5升氧气/分钟的治疗应与重症监护同事密切合作,优选在重症监护病房>15升/分钟。高流量鼻插管(HFNC)和长期持续气道正压通气(CPAP)建议对常规氧疗无反应的患者。无创通气(NIV)仅推荐用于特定患者。例如那些有治疗上限的患者或表现为高碳酸血症衰竭的患者。使用加湿防护设备时,应使用FFP2-3口罩。应避免雾化用药,和垫片应改为使用。
结论:呼吸衰竭通常是COVID-19患者住院的原因,应密切监测。